Publicações

Guidance Adherent Dabigatran Etexilate Treatment Versus Warfarin in the Re-Ly Population: an Analysis on the Basis of the European Label Recommendations for Dabigatran Etexilate

AuthID
P-006-K17

Author(s)

Lip, G

Clemens, A

Noack, H

Ferreira, J

Connolly, S

Yusuf, S

Tipo de Documento

Abstract

Year published

2013

Publicado

in EUROPEAN HEART JOURNAL, ISSN: 0195-668X

Volume: 34, Páginas: 791-791 (1)

Conference

Congress of the European-Society-Of-Cardiology (Esc), Date: AUG 31-SEP 04, 2013, Location: Amsterdam, NETHERLANDS, Patrocinadores: European Soc Cardiol

Indexing

Wos^®

Metadata
Fontes

Publication Identifiers

Wos: WOS:000327744604640

Source Identifiers

ISSN: 0195-668X

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Guidance Adherent Dabigatran Etexilate Treatment Versus Warfarin in the Re-Ly Population: an Analysis on the Basis of the European Label Recommendations for Dabigatran Etexilate

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Guidance Adherent Dabigatran Etexilate Treatment Versus Warfarin in the Re-Ly Population: an Analysis on the Basis of the European Label Recommendations for Dabigatran Etexilate

Links Úteis

Ajuda